Cisapride for gastro-oesophageal reflux and peptic oesophagitis.


Twenty children (age range 75 days-47 months) with reflux oesophagitis entered a random double blind trial in which they received either Cisapride (Janssen Pharmaceutical Ltd), a new prokinetic agent, or an identical placebo syrup. Diagnosis of gastro-oesophageal reflux was made by measurement of intraluminal oesophageal pH combined with manometry… (More)


2 Figures and Tables

Cite this paper

@article{Cucchiara1987CisaprideFG, title={Cisapride for gastro-oesophageal reflux and peptic oesophagitis.}, author={Stefania Cucchiara and Antonino Staiano and Charles J Capozzi and Carlo Di Lorenzo and Armando Boccieri and Sara Auricchio}, journal={Archives of disease in childhood}, year={1987}, volume={62 5}, pages={454-7} }